Evidence map›Paper›PMID 41628965›Full record

ArticleSaudi medical journal2026

Gender Differences in Sociodemographic and Clinical Characteristics of Methamphetamine Use in Saudi Arabia.

Halima M Adam, Mohamed Abouzed, Ahmed H Aljadani, Benayan B Alrasheedy, Muath A Alarfaj, Salwa R Alshammari, Mohamed S Almuqahwi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Halima M AdamPsychology Department, Education College, University of Ha'il, Hail, Saudi Arabia.
Mohamed AbouzedDepartment of Psychiatry, College of Medicine, Al-Azhar University, Cairo, Egypt.
Ahmed H AljadaniCollege of Medicine, University of Ha'il, Hail, Saudi Arabia.
Benayan B AlrasheedyPsychology Department, Education College, University of Ha'il, Hail, Saudi Arabia.
Muath A AlarfajEradah Complex for Mental Health, Hail, Saudi Arabia.
Salwa R AlshammariEradah Complex for Mental Health, Hail, Saudi Arabia.
Mohamed S AlmuqahwiEradah Complex for Mental Health, Dammam, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo explore gender-related variations in sociodemographic factors, clinical presentations, and psychosocial characteristics among methamphetamine users in Saudi Arabia.

methodsA retrospective cross-sectional study was conducted using the electronic health records of 1,181 patients (91% male, 9% female) treated at multiple Erada Mental and Addiction Centers across Saudi Arabia (2020-2024). Data on sociodemographic characteristics, methamphetamine use patterns, psychiatric comorbidities, and psychosocial functioning were collected and analyzed using validated tools, including the Addiction Severity Index, Beck Depression and Anxiety Inventory, and Quality of Life Scale.

resultsFemale participants were younger than males (mean age 25.3 vs 28.5 years;

conclusionsFemale methamphetamine users demonstrate greater vulnerability with earlier onset, more psychiatric comorbidities, and worse psychosocial outcomes. Targeted interventions are needed for female methamphetamine users in Saudi Arabia.

Indexed as

Amphetamine-Related DisordersMethamphetamineAdultCross-Sectional StudiesFemaleHumansMaleQuality of LifeRetrospective StudiesSaudi ArabiaSex FactorsSociodemographic FactorsSocioeconomic FactorsYoung AdultMethamphetaminegender differencesMethamphetamineSaudi Arabiastimulantsubstance use disorder

Identifiers

PMID41628965
PMCPMC12971113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.